13种抗菌药物对尿路感染患者摩根菌-变形杆菌-普罗威登斯菌属细菌的体外活性比较
Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
作者信息
Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Ravagnan G
机构信息
Istituto di Medicina Sperimentale, Facoltà di Medicina e Chirurgia, Università degli Studi G. D'Annunzio, Chieti, Italy.
出版信息
Antimicrob Agents Chemother. 1987 Oct;31(10):1644-7. doi: 10.1128/AAC.31.10.1644.
Abstract
We examined 741 urinary tract isolates of the Morganella-Proteus-Providencia group, including the recently defined species Proteus penneri, for susceptibilities to aminoglycosides, semisynthetic penicillins, and cephalosporins. The data emphasize the importance of identification to the species level on the basis of marked species differences in patterns of susceptibility.
摘要
我们检测了摩根菌属-变形杆菌属-普罗威登斯菌属菌群的741株泌尿道分离菌，包括最近定义的彭氏变形杆菌，以了解它们对氨基糖苷类、半合成青霉素和头孢菌素的敏感性。这些数据强调了基于显著的种间敏感性差异进行种水平鉴定的重要性。
相似文献
1
Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.13种抗菌药物对尿路感染患者摩根菌-变形杆菌-普罗威登斯菌属细菌的体外活性比较
Antimicrob Agents Chemother. 1987 Oct;31(10):1644-7. doi: 10.1128/AAC.31.10.1644.
2
[Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].[摩根菌-变形杆菌-普罗威登斯菌属细菌临床分离株的抗菌药敏性]
Jpn J Antibiot. 1991 Feb;44(2):140-9.
3
Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.变形杆菌属细菌对六种头孢菌素和三种氨基糖苷类抗生素敏感性的种间差异。
Antimicrob Agents Chemother. 1982 Aug;22(2):218-21. doi: 10.1128/AAC.22.2.218.
4
Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.变形杆菌属、普罗威登斯菌属和摩根菌属的分类、鉴定及临床意义
Clin Microbiol Rev. 2000 Oct;13(4):534-46. doi: 10.1128/CMR.13.4.534.
5
[Antimicrobial susceptibility patterns of the Proteeae in Japan, 1989].[1989年日本变形杆菌族的抗菌药敏模式]
Jpn J Antibiot. 1993 Apr;46(4):285-94.
6
Activities of oral antibiotics on Providencia strains isolated from institutionalized elderly patients with urinary tract infections.口服抗生素对从患有尿路感染的机构养老患者中分离出的普罗威登斯菌菌株的活性。
Antimicrob Agents Chemother. 1995 Dec;39(12):2819-21. doi: 10.1128/AAC.39.12.2819.
7
Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection.引起尿路感染的革兰氏阴性菌中的抗菌和抗生素耐药性。
J Clin Pathol. 1980 Mar;33(3):288-96. doi: 10.1136/jcp.33.3.288.
8
Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.头孢菌素与氨基糖苷类抗生素对普罗威登斯菌属和变形杆菌属的协同作用。
Antimicrob Agents Chemother. 1974 Jun;5(6):571-7. doi: 10.1128/AAC.5.6.571.
9
High prevalence of multiple drug resistant enteric bacteria: Evidence from a teaching hospital in Southwest Nigeria.高比例多重耐药肠细菌：来自尼日利亚西南部一所教学医院的证据。
J Infect Public Health. 2020 Apr;13(4):651-656. doi: 10.1016/j.jiph.2019.08.014. Epub 2019 Sep 13.
10
Differences among Providencia species in their in vitro susceptibilities to five antibiotics.普罗威登斯菌属各菌种对五种抗生素的体外敏感性差异。
Antimicrob Agents Chemother. 1980 Dec;18(6):868-71. doi: 10.1128/AAC.18.6.868.
引用本文的文献
1
Potential virulence factors of Proteus bacilli.变形杆菌属细菌的潜在毒力因子。
Microbiol Mol Biol Rev. 1997 Mar;61(1):65-89. doi: 10.1128/mmbr.61.1.65-89.1997.
2
Analysis of antibiotic resistance determinants in Proteus penneri.彭氏变形杆菌抗生素耐药决定因素分析
Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):467-9. doi: 10.1007/BF01967445.
本文引用的文献
1
Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1.彭氏变形杆菌新种的鉴定，该菌以前被称为吲哚阴性普通变形杆菌或普通变形杆菌生物群1。
J Clin Microbiol. 1982 Jun;15(6):1097-102. doi: 10.1128/jcm.15.6.1097-1102.1982.
2
Comparative in vitro activity of semisynthetic penicillins against Proteeae.半合成青霉素对变形杆菌属的体外活性比较
Antimicrob Agents Chemother. 1983 Apr;23(4):619-21. doi: 10.1128/AAC.23.4.619.
3
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.阴沟肠杆菌和铜绿假单胞菌中的头孢菌素酶截留不可水解头孢菌素作为一种可能的耐药机制。
Antimicrob Agents Chemother. 1982 May;21(5):711-7. doi: 10.1128/AAC.21.5.711.
4
Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.变形杆菌属细菌对六种头孢菌素和三种氨基糖苷类抗生素敏感性的种间差异。
Antimicrob Agents Chemother. 1982 Aug;22(2):218-21. doi: 10.1128/AAC.22.2.218.
5
Proteus penneri and urinary calculi formation.彭氏变形杆菌与尿路结石形成
J Clin Microbiol. 1984 Apr;19(4):541-2. doi: 10.1128/jcm.19.4.541-542.1984.
6
Emerging bacterial resistance to the newer cephalosporins.新出现的细菌对新型头孢菌素的耐药性。
J Antimicrob Chemother. 1984 May;13(5):526-7. doi: 10.1093/jac/13.5.526.
7
Inducible beta-lactamases and non-hydrolytic resistance mechanisms.可诱导β-内酰胺酶及非水解性耐药机制
J Antimicrob Chemother. 1984 Jan;13(1):1-3. doi: 10.1093/jac/13.1.1.
8
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.新型β-内酰胺类抗生素治疗期间耐药性的出现：诱导性β-内酰胺酶的作用及对未来的影响。
Rev Infect Dis. 1983 Jul-Aug;5(4):639-48. doi: 10.1093/clinids/5.4.639.
9
Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.阴沟肠杆菌的染色体β-内酰胺酶是导致对第三代头孢菌素耐药的原因。
Antimicrob Agents Chemother. 1983 Jun;23(6):918-25. doi: 10.1128/AAC.23.6.918.
10
Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.
J Antimicrob Chemother. 1984 Sep;14 Suppl B:13-21. doi: 10.1093/jac/14.suppl_b.13.
Zotero 插件